Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
Saibeni S, Scucchi L, Dragoni G, Bezzio C, Miranda A, Ribaldone DG, Bertani A, Bossa F, Allocca M, Buda A, Mocci G, Soriano A, Mazzuoli S, Bertani L, Baccini F, Loddo E, Privitera AC, Sartini A, Viscido A, Grossi L, Casini V, Gerardi V, Ascolani M, Ruscio MD, Casella G, Savarino E, Stradella D, Pumpo R, Cortelezzi CC, Daperno M, Ciardo V, Nardone OM, Caprioli F, Vitale G, Cappello M, Comberlato M, Alvisi P, Festa S, Campigotto M, Bodini G, Balestrieri P, Viola A, Pugliese D, Armuzzi A, Fantini MC, Fiorino G; IG-IBD (Italian Group for the study of Inflammatory Bowel Disease). Saibeni S, et al. Among authors: daperno m. United European Gastroenterol J. 2020 Dec;8(10):1228-1235. doi: 10.1177/2050640620964132. Epub 2020 Oct 18. United European Gastroenterol J. 2020. PMID: 33070758 Free PMC article.
The role of endoscopy in inflammatory bowel disease.
Daperno M, Sostegni R, Lavagna A, Crocellà L, Ercole E, Rigazio C, Rocca R, Pera A. Daperno M, et al. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct;8(5):209-14. Eur Rev Med Pharmacol Sci. 2004. PMID: 15638232 Review.
Pulmonary manifestations of inflammatory bowel disease.
Sostegni R, Daperno M, Pera A. Sostegni R, et al. Among authors: daperno m. Dig Liver Dis. 2007 Mar;39(3):239-41. doi: 10.1016/j.dld.2006.11.007. Epub 2007 Jan 30. Dig Liver Dis. 2007. PMID: 17267308 No abstract available.
Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study.
Bortoli A, Saibeni S, Tatarella M, Prada A, Beretta L, Rivolta R, Politi P, Ravelli P, Imperiali G, Colombo E, Pera A, Daperno M, Carnovali M, de Franchis R, Vecchi M; Study Group for Inflammatory Bowel Diseases GSMII. Bortoli A, et al. Among authors: daperno m. J Gastroenterol Hepatol. 2007 Apr;22(4):542-9. doi: 10.1111/j.1440-1746.2006.04754.x. J Gastroenterol Hepatol. 2007. PMID: 17376049
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Viscido A, Annese V, Riegler G, Meucci G, Marrollo M, Sostegni R, Gasbarrini A, Peralta S, Prantera C. Kohn A, et al. Among authors: daperno m. Aliment Pharmacol Ther. 2007 Sep 1;26(5):747-56. doi: 10.1111/j.1365-2036.2007.03415.x. Aliment Pharmacol Ther. 2007. PMID: 17697208 Free article.
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.
Cottone M, Kohn A, Daperno M, Armuzzi A, Guidi L, D'Inca R, Bossa F, Angelucci E, Biancone L, Gionchetti P, Ardizzone S, Papi C, Fries W, Danese S, Riegler G, Cappello M, Castiglione F, Annese V, Orlando A. Cottone M, et al. Among authors: daperno m. Clin Gastroenterol Hepatol. 2011 Jan;9(1):30-5. doi: 10.1016/j.cgh.2010.09.026. Epub 2010 Oct 15. Clin Gastroenterol Hepatol. 2011. PMID: 20951835
The prevalence of hyper- and hypothyroidism in patients with ulcerative colitis.
Casella G, De Marco E, Antonelli E, Daperno M, Baldini V, Signorini S, Sannella F, Morelli A, Villanacci V, Bassotti G. Casella G, et al. Among authors: daperno m. J Crohns Colitis. 2008 Dec;2(4):327-30. doi: 10.1016/j.crohns.2008.09.001. Epub 2008 Oct 22. J Crohns Colitis. 2008. PMID: 21172232
Adalimumab in active ulcerative colitis: a "real-life" observational study.
Italian Group for the Study of Inflammatory Bowel Disease; Armuzzi A, Biancone L, Daperno M, Coli A, Pugliese D, Annese V, Aratari A, Ardizzone S, Balestrieri P, Bossa F, Cappello M, Castiglione F, Cicala M, Danese S, D'Incà R, Dulbecco P, Feliciangeli G, Fries W, Genise S, Gionchetti P, Gozzi S, Kohn A, Lorenzetti R, Milla M, Onali S, Orlando A, Papparella LG, Renna S, Ricci C, Rizzello F, Sostegni R, Guidi L, Papi C. Italian Group for the Study of Inflammatory Bowel Disease, et al. Among authors: daperno m. Dig Liver Dis. 2013 Sep;45(9):738-43. doi: 10.1016/j.dld.2013.03.018. Epub 2013 May 15. Dig Liver Dis. 2013. PMID: 23683530 Free article.
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
Monterubbianesi R, Aratari A, Armuzzi A, Daperno M, Biancone L, Cappello M, Annese V, Riegler G, Orlando A, Viscido A, Meucci G, Gasbarrini A, Guidi L, Lavagna A, Sostegni R, Onali S, Papi C, Kohn A; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD). Monterubbianesi R, et al. Among authors: daperno m. J Crohns Colitis. 2014 Aug;8(8):852-8. doi: 10.1016/j.crohns.2014.01.006. Epub 2014 Jan 25. J Crohns Colitis. 2014. PMID: 24472490
122 results